Skip to main content

Table 1 Epidemiological associations with PVL status

From: Epidemiological, clinical, outcome and antibiotic susceptibility differences between PVL positive and PVL negative Staphylococcus aureus infections in Western Australia: a case control study

Characteristic PVL positive (n = 141) PVL negative (n = 148) p-value
Age (median) 37 58 <0.001
Male 102 (72.3) 93 (62.8) 0.085
Indigenous 48 (34.0) 18 (12.2) <0.001
Intravenous Drug Use 23 (16.3) 10 (6.8) 0.011
Haematological malignancy 0 (0) 6 (4.1) 0.016
Solid malignancy 2 (1.4) 14 (9.5) 0.003
Diabetes Mellitus 31 (22) 44 (29.7) 0.133
Immunosuppressive treatment 7 (5) 14 (9.5) 0.141
HIV positive 3 (2.1) 2 (1.4) 0.613
Pre-existing skin condition 4 (2.8) 4 (2.7) 0.945
Hospitalisation in the past year 50 (35.5) 92 (61.2) <0.001
Long term care facility resident 2 (1.4) 22 (14.9) <0.001
“Community acquired” infection 87 (61.7) 35 (23.6) <0.001
“Healthcare associated” infection 46 (32.6) 78 (52.7) <0.001
“Hospital acquired” infection 8 (5.7) 35 (23.6) <0.001
  1. Number (%).